National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

被引:10
|
作者
Gori, Niccolo [1 ,2 ]
Chiricozzi, Andrea [1 ,2 ]
Marsili, Franco [3 ]
Ferrucci, Silvia Mariel [4 ]
Amerio, Paolo [5 ]
Battarra, Vincenzo [6 ]
Campitiello, Salvatore [7 ]
Castelli, Antonio [8 ]
Congedo, Maurizio [9 ]
Corazza, Monica [10 ]
Cristaudo, Antonio [11 ]
Fabbrocini, Gabriella [12 ]
Girolomoni, Giampiero [13 ]
Malara, Giovanna [14 ]
Micali, Giuseppe [15 ]
Palazzo, Giovanni [16 ]
Parodi, Aurora [17 ]
Patrizi, Annalisa [18 ]
Pellacani, Giovanni [19 ]
Pigatto, Paolo [20 ]
Provenzano, Eugenio [21 ]
Quaglino, Pietro [22 ]
Romanelli, Marco [23 ]
Rossi, Mariateresa [24 ]
Savoia, Paola [25 ]
Peris, Ketty [1 ,2 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli, Dipartimento Sci Med Chirurg, UOC Dermatol, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Med Chirurg Traslaz, Dermatol, I-00168 Rome, Italy
[3] Versilia Hosp, Dermatol Unit, ASL 12, I-55049 Lido Di Camaiore, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, I-20122 Milan, Italy
[5] Univ G dAnnunzio, Dept Med & Aging Sci, Dermatol Clin, I-66100 Chieti, Italy
[6] AORN St Anna & San Sebastiano, Unit Dermatol, I-81100 Caserta, Italy
[7] ASL Salerno, Osped Tortora Pagani, UOC Dermatol, I-84016 Salerno, Italy
[8] San Donato Hosp, Dermatol Unit, ASL 8, I-52100 Arezzo, Italy
[9] Vito Fazzi Hosp, Sect Dermatol, Piazza Filippo Muratore, I-73100 Lecce, Italy
[10] Univ Ferrara, Dept Med Sci, Sect Dermatol & Infect Dis, I-44121 Ferrara, Italy
[11] Ist Dermatol San Gallicano IRCSS, IFO, I-00100 Rome, Italy
[12] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy
[13] Univ Verona, Dept Med, Sect Dermatol & Venereol, I-37129 Verona, Italy
[14] Grande Osped Metropolitano Bianchi Melacrino Mor, Struttura Complessa Dermatol, I-89129 Reggio Di Calabria, Italy
[15] Univ Catania, Dermatol Clin, I-95123 Catania, Italy
[16] Osped Distrettuale Tinchi, Ambulatorio Dermatol, I-75015 Pisticci, Italy
[17] Univ Genoa, Osped, Policlin San Martino IRCCS, DiSSal Sect Dermatol, I-16132 Genoa, Italy
[18] Univ Bologna, Dept Expt Diagnost & Specialty Med, Div Dermatol, I-40138 Bologna, Italy
[19] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Dermatol Clin, I-00161 Rome, Italy
[20] IRCCS Osped Ortped Galeazzi, Dept Med Surg & Odntiatr Sci, I-20161 Milan, Italy
[21] Mariano Santo Hosp, Unit Dermatol, I-87100 Cosenza, Italy
[22] Univ Turin, Dept Med Sci, Dermatol Clin, I-10121 Turin, Italy
[23] Univ Pisa, Dermatol Dept, Via Roma 67, I-56126 Pisa, Italy
[24] Univ Brescia, Dept Dermatol, I-25121 Brescia, Italy
[25] Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy
关键词
atopic dermatitis; information campaign; early diagnosis; MANAGEMENT; DUPILUMAB; MODERATE; DERMATOLOGY; GUIDELINES; DIAGNOSIS; CONSENSUS; CRITERIA; CHILDREN; ECZEMA;
D O I
10.3390/jcm11175204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The burden of atopic dermatitis in US adults: results from the 2013 National Health and Wellness Survey
    Whiteley, Jennifer
    Emir, Birol
    Seitzman, Robin
    Makinson, Geoffrey
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1645 - 1651
  • [22] Global, regional, and national burden of older adult atopic dermatitis in 204 countries and territories worldwide
    Ou, Yi
    Shao, Xinyi
    Zhang, Jingbo
    Chen, Jin
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [23] Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)
    Jerry Bagel
    Tien Q. Nguyen
    Hermenio Lima
    Neal Jain
    David M. Pariser
    Sylvia Hsu
    Gil Yosipovitch
    Haixin Zhang
    Jingdong Chao
    Shikha Bansal
    Zhen Chen
    Daniel Richman
    Andrew Korotzer
    Marius Ardeleanu
    Dermatology and Therapy, 2022, 12 : 1417 - 1430
  • [24] The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019
    Dong, Wen-lan
    An, Jing
    Yu, Miao
    Yin, Peng
    Xu, Ting-ling
    Liu, Bo
    Zuberbier, Torsten
    Zhao, Zuo-tao
    Zhou, Mai-geng
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (11):
  • [25] Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
    Fuxench, Zelma C. Chiesa
    Block, Julie K.
    Boguniewicz, Mark
    Boyle, John
    Fonacier, Luz
    Gelfand, Joel M.
    Grayson, Mitchell H.
    Margolis, David J.
    Mitchell, Lynda
    Silverberg, Jonathan, I
    Schwartz, Lawrence
    Simpson, Eric L.
    Ong, Peck Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (03) : 583 - 590
  • [26] Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults
    Ring, J.
    Zink, A.
    Arents, B. W. M.
    Seitz, I. A.
    Mensing, U.
    Schielein, M. C.
    Wettemann, N.
    de Carlo, G.
    Fink-Wagner, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (07) : 1331 - 1340
  • [27] Global Burden of Atopic Dermatitis Examining Disease Prevalence Across Pediatric and Adult Populations World-Wide
    Durango, Kevin Puerta
    Fuxench, Zelma C. Chiesa
    DERMATOLOGIC CLINICS, 2024, 42 (04) : 519 - 525
  • [28] The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey
    Eckert, Laurent
    Gupta, Shaloo
    Amand, Caroline
    Gadkari, Abhijit
    Mahajan, Puneet
    Gelfand, Joel M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 54 - +
  • [29] Evaluation of Peripheral Blood Eosinophilia in Adolescent and Adult Patients Suffering from Atopic Dermatitis and the Relation to the Occurrence of Allergy to Aeroallergens
    Celakovska, Jarmila
    Bukac, Josef
    Ettler, Karel
    Vaneckova, Jaroslava
    Krcmova, Irena
    Ettlerova, Kvetuse
    Krejsek, Jan
    INDIAN JOURNAL OF DERMATOLOGY, 2019, 64 (01) : 34 - 40
  • [30] Treatment of adult atopic dermatitis patients according to disease characteristics and demographics
    Thyssen, Jacob P.
    Andersen, Yuki M. F.
    Vittrup, Ida
    Pierce, Evangeline
    DeLozier, Amy
    Egeberg, Alexander
    DERMATOLOGIC THERAPY, 2020, 33 (06)